$38.78 +0.96 (2.52%)

Bruker Corporation (BRKR)

Bruker Corporation (BRKR) is a global leader in scientific instrumentation and analytical solutions. It specializes in high-performance tools for molecular and materials research, including mass spectrometry, nuclear magnetic resonance (NMR), and other analytical techniques. The company's products are widely used in healthcare, pharmaceuticals, academia, and industrial research to support scientific discovery and quality control.

Dividend Yield 0.52%
Payout Frequency Quarterly

Dividend History

Pay DateAmountEx-DateRecord Date
October 3, 2025$0.052025-09-232025-09-23
June 27, 2025$0.052025-06-162025-06-16
March 28, 2025$0.052025-03-172025-03-17
December 16, 2024$0.052024-12-022024-12-02
September 16, 2024$0.052024-08-302024-09-02

Dividends Summary

Company News

PFAS Testing Market Outlook, 2037 - Opportunities Driven by Environmental and Health Concerns
GlobeNewswire Inc. • Researchandmarkets.Com • October 17, 2025

The global PFAS testing market is projected to grow from $306.60 million in 2024 to $1.25 billion by 2037, driven by increasing environmental and health regulations around 'forever chemicals' across North America, Europe, and Asia.

Why Bruker Stock Tumbled by Almost 12% Wednesday
The Motley Fool • Eric Volkman • September 4, 2025

Medical device company Bruker announced a $600 million mandatory convertible preferred stock offering to retire debt, causing an 11.68% stock price decline on Wednesday.

Wall Street Extends Records, Gold Rallies To $3,400: What's Moving Markets Monday?
Benzinga • Piero Cingari • July 21, 2025

Wall Street indices extended record highs on strong earnings and investor confidence, with gold prices surging to $3,400 amid dollar weakness and speculation about Federal Reserve leadership.

Zacks Industry Outlook Mettler-Toledo and Bruker
Zacks Investment Research • Zacks Equity Research • August 6, 2024

The Instruments - Scientific industry is benefiting from increasing healthcare spending, driven by aging demography, and continued innovation in the pharma and life sciences end markets. Mettler-Toledo and Bruker are gaining from the growing testing needs of newer biological drugs and the increasing demand for automated solutions.

Michael Burry’s Scion Asset Management scoops up shares of Alphabet, Amazon
MarketWatch • MarketWatch • February 14, 2024

Michael Burry’s Scion Asset Management scooped up shares of Alphabet Inc. and Amazon.com Inc. during the fourth quarter of 2023

Related Companies